Login
Navigate Fool.com
Will PBIO beat
the market?

PRESSURE BIOSCIENCES, INC.

NASDAQOTH: PBIO

Community Rating: Unrated

0.44 -0.03 (-5.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.45
Previous Close $0.46
Daily Range $0.45 - $0.45
52-Week Range $0.16 - $0.78
Market Cap $4.5M
P/E Ratio -1.05
Dividend (Yield) $0.00 (0.0%)
Volume 9,349
Average Daily Volume 84,061
Current FY EPS -$0.27

How do you think PBIO
will perform against the market?

Top PBIO Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

The World's Most Expensive Mutual Fund

This fund takes the cake for sky-high expenses.

PBIO continues to move in a positive direction - Analyst Blog

Strategic Collaboration Means Better Penetration in the Sample Preparation Market - Analyst Blog

Expanded Collaboration with TDI Could Mean Increased Revenue - Analyst Blog

Expanded Collaboration with TDI Could Mean Increased Revenue - Analyst Blog

DCF Model Confirms “Strong Buy” For Pressure BioSciences

Pressure BioSciences May Be 2012's Top Stock

Pressure BioSciences (PBIO) Ready To Take Off

New Co-marketing Agreement May Boost PBIO's Sales Immediately - Analyst Blog

New Co-marketing Agreement May Boost PBIO's Sales Immediately - Analyst Blog

New Distribution Could Boost PBIO's Sales Immediately - Analyst Blog

New Distribution Could Boost PBIO's Sales Immediately - Analyst Blog

New Distribution Could Boost PBIO???s Sales Immediately - Analyst Blog

New Distribution Could Boost PBIO???s Sales Immediately - Analyst Blog

PBIO Is Poised to Grow in 2012 - Analyst Blog

PBIO Is Poised to Grow in 2012 - Analyst Blog

See More PBIO News...

Sector

Healthcare

Industry

Life Sciences Tools and Services

PRESSURE BIOSCIENCES, INC. (PBIO) Description

The Company is engaged in the research, development and commercialization of products utilizing its patented pressure cycling technology, a novel platform technology for the control of bio-molecular interactions. Website:

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks